Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    0.00 (0.00%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Half-Year Update

24 Jul 2025 07:00

RNS Number : 3051S
Onward Opportunities Limited
24 July 2025
Β 

24 July 2025

Β 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

Β 

Half-Year Update

Β 

Onward Opportunities Limited (AIM: ONWD), the investment company that invests in UK smaller companies, provides an update in respect of the six-month period ended 30 June 2025 ("HY25"), ahead of publication of the Company's unaudited HY25 interim results in September 2025.

Β 

Company Update

Β 

Β· 30 June 2025 net asset value ("NAV") per share of 128.41 pence, equating to a total return of +10.39% over the 12-month period from 30 June 2024 (NAV: 116.32p), maintaining the encouraging record of NAV outperformance since launch and during a period of significant market volatility

Β 

Β· 27-month NAV per share return in the period since inception to 30 June 2025 of +28.41%:

Β 

oΒ  Outperformed the UK AIM All Share index Total Return by +31.6% (UK AIM All Share: -3%)

Β 

oΒ  Top decile performance amongst peers in the sector over 2-years with the Portfolio Manager ranked second out of all peers on Citywire Ratings Table for UK Smaller Companies IT

Β 

oΒ  Delivered the Company's stated target returns of >15% IRR during the period

Β 

Β· Successfully completed two capital raises year to date, raising additional proceeds of in excess of Β£4.1m from new and existing investors, increasing the Company's capital base by more than 10% and providing it with additional resources with which to apply towards identified attractive investment opportunities

Β 

Β· Cash balances peaked at c.22% in the latter part of the first quarter, with the majority profitably invested during April

Β 

Β· The Portfolio Manager was nominated for Fund Manager of the Year at both the City AM Awards 2025 and the PLC Awards, in recognition of the Company's strong early performance

Β 

Portfolio Update

Β 

Β· Proceeds from the takeover of Windward received, generating cash profits of Β£2.4m, an IRR of 141.1% and a 2.5x multiple on invested capital

Β 

Β· Significant progress at a number of holdings in spite of global macroeconomic headwinds; Angling Direct (record trading), Likewise (record trading), Venture Life Group (material disposal), The Mission Group (material disposal), Frenkel Topping (indicative takeover offer), Audioboom Group (record trading), Synectics (upgrades and contract wins), Alumasc (international expansion). Performance detractors at MPAC Group (US division slowdown since liberation day), Northcoders (government contract lost), REACT Group (profits warning)

Β 

Β· The depth of the investment pipeline is the healthiest it has been in 12-months, with a number of new core and nursery investments expected in the third quarter, with recent capital raises providing the necessary resources. Recent new nursery holdings include Boku, Light Science Technologies and Venture Life Group

Β 

Β 

Laurence Hulse, Lead Fund Manager, said:

Β 

"Onward has navigated its first market crisis since launch in 2023. Cash balances had been patiently built up by the Manager at the start of the year and a disciplined approach held liquid reserves back during the first few months of volatility. These were then deployed profitably during April, setting the portfolio up for recovery and growth in the second half of the year. The team is focussed on capturing the near-term pipeline in order to extend our emerging track record of material outperformance."

Β 

For further information, please contact:

Β 

Β 

Onward Opportunities Limited

Andrew Henton, Chairman

Β 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Lead Fund Manager

Β 

Β 

Tel: +44 (0) 203 5303 150

ool@maitlandgroup.com

Β 

Tel: +44 (0) 203 5303 150

ool@maitlandgroup.com

Β 

Β 

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Hamish Waller - Corporate Finance

Chris West / Matt Lewis - Sales and ECM

Β 

Tel: +44 (0)20 7220 0500

Dowgate Capital Limited (Joint Broker)

Nicholas Chambers / Daniel Ingram

Β 

Tel: +44 (0)12 9351 7744

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDBLGDRSBDDGUX
12
Date   Source Headline
13th Nov 202510:32 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:00 amRNSNet Asset Value(s)
16th Oct 20254:54 pmRNSHolding(s) in Company
14th Oct 20251:09 pmRNSPublication of Q3 2025 Factsheet
10th Oct 20257:00 amRNSAdditional Subscription and Total Voting Rights
7th Oct 20257:00 amRNSIssue of Equity
1st Oct 20253:33 pmRNSNet Asset Value(s)
8th Sep 20257:00 amRNSHalf-year Report
2nd Sep 20257:00 amRNSNet Asset Value(s)
4th Aug 202512:57 pmRNSNet Asset Value(s)
25th Jul 202510:05 amRNSHolding(s) in Company
24th Jul 20257:00 amRNSHalf-Year Update
21st Jul 20257:00 amRNSAdditional Subscription and Total Voting Rights
16th Jul 20257:00 amRNSIssue of Equity
7th Jul 20257:00 amRNSPublication of Q2 2025 Factsheet
2nd Jul 20253:47 pmRNSNet Asset Value(s)
16th Jun 202512:49 pmRNSResult of AGM
3rd Jun 20257:00 amRNSNet Asset Value
2nd Jun 20257:00 amRNS-RInaugural Investor Day
29th May 20257:00 amRNSNotice of AGM
7th May 20251:29 pmRNSDirector Dealing
6th May 20257:00 amRNSChange of Service Providers and Registered Office
2nd May 20259:26 amRNSNet Asset Value(s)
16th Apr 20255:33 pmRNSHolding(s) in Company
2nd Apr 20252:50 pmRNSNet Asset Value(s)
20th Mar 20257:00 amRNSAdditional Subscription and Total Voting Rights
18th Mar 20257:00 amRNSAnnual Results
14th Mar 20257:00 amRNSIssue of Equity and Total Voting Rights
11th Mar 20255:02 pmRNSHolding(s) in Company
4th Mar 20254:59 pmRNSNet Asset Value(s)
4th Feb 20255:10 pmRNSHolding(s) in Company
4th Feb 20251:46 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSAmalgamation of Administrator
16th Jan 20257:00 amRNSPublication of Q4 2024 Factsheet
14th Jan 20257:00 amRNSFull-Year Update
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.